Balyasny Asset Management LLC raised its holdings in shares of athenahealth, Inc. (NASDAQ:ATHN) by 2,243.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 111,429 shares of the health services provider’s stock after acquiring an additional 106,674 shares during the quarter. Balyasny Asset Management LLC owned approximately 0.28% of athenahealth worth $15,661,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the business. Turner Investments LLC acquired a new stake in athenahealth during the second quarter valued at $105,000. FNY Partners Fund LP grew its stake in athenahealth by 1,900.0% in the first quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after purchasing an additional 950 shares in the last quarter. Bessemer Group Inc. increased its position in athenahealth by 13.7% in the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock worth $132,000 after purchasing an additional 113 shares during the last quarter. Seven Bridges Advisors LLC increased its position in athenahealth by 5.4% in the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after purchasing an additional 67 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its position in athenahealth by 123.8% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after purchasing an additional 744 shares during the last quarter.

athenahealth, Inc. (NASDAQ ATHN) opened at 123.51 on Wednesday. athenahealth, Inc. has a 12-month low of $90.11 and a 12-month high of $158.66. The company has a market cap of $4.93 billion, a P/E ratio of 156.74 and a beta of 1.76. The stock’s 50 day moving average is $132.79 and its 200 day moving average is $129.75.

athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.12. The firm had revenue of $301.10 million during the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The company’s revenue was up 15.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.34 EPS. On average, equities analysts forecast that athenahealth, Inc. will post $1.91 earnings per share for the current year.

WARNING: “athenahealth, Inc. (ATHN) Stake Raised by Balyasny Asset Management LLC” was reported by Marea Informative and is the property of of Marea Informative. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at http://www.mareainformativa.com/athenahealth-inc-athn-stake-raised-by-balyasny-asset-management-llc/115147/.

A number of equities research analysts have recently weighed in on the company. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $170.00 price target (up from $150.00) on shares of athenahealth in a research note on Wednesday, August 2nd. Cowen and Company cut athenahealth from an “outperform” rating to a “market perform” rating and boosted their price target for the company from $127.00 to $133.00 in a research note on Monday, July 31st. Morgan Stanley reissued an “equal weight” rating and issued a $125.00 price target (up previously from $108.00) on shares of athenahealth in a research note on Wednesday, August 2nd. Citigroup Inc. restated a “buy” rating and issued a $186.00 price objective (up previously from $169.00) on shares of athenahealth in a report on Monday, July 24th. Finally, ValuEngine upgraded athenahealth from a “sell” rating to a “hold” rating in a report on Monday, July 24th. Three equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and twelve have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $149.91.

In related news, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $124.17, for a total transaction of $496,680.00. Following the sale, the chief executive officer now owns 319,807 shares in the company, valued at approximately $39,710,435.19. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Brandon H. Hull sold 800 shares of the stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $140.01, for a total transaction of $112,008.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 16,505 shares of company stock worth $2,240,851. 3.20% of the stock is currently owned by insiders.

athenahealth Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.